• Blog Home
  • Health Tips
  • Dental
  • Mental Health
  • Healthcare
  • Company News
  • Weekly News

Who’s The Most Likely to Be Uninsured?

March 29, 2018 by Courtney Elder

Who’s The Most Likely to Be Uninsured?

Just because you are employed doesn’t mean that you will have the luxury of health insurance. Despite the fact that states mandate specific insurance requirements based on the number of employees in the company, statistics show a different story. In 2016 alone, 27.6 million people did not have health coverage. Of those individuals, 75% of them had at least one full-time ... Continue Reading

Penguin Pay Breakthrough! Loans for Prescription Drugs

March 28, 2018 by SingleCare

Penguin Pay Breakthrough! Loans for Prescription Drugs

Introducing Penguin Pay, a feature exclusive to SingleCare. We are often told to save up for the unexpected. But often, needing to fill a costly prescription is outside of our budget, our plans and what we can reasonably afford. There you are, saving up for [one hundred other daily essentials] when you get hit with a prescription drug cost that's several hundred dollars (or ... Continue Reading

Erleada, A New Prostate Cancer Treatment

March 26, 2018 by SingleCare

Erleada, A New Prostate Cancer Treatment

As of February 2018, the FDA approved Erleada (also known by its generic name of apalutamide) a new drug for the treatment of certain types of prostate cancer. While there are many drugs available to treat prostate cancer, this is the first that the FDA has approved for hormone-resistant non-spreading (castration-resistant non-metastatic) tumors. The approval is welcome news ... Continue Reading

FDA Approves Biktarvy for Use in HIV Regimens

March 26, 2018 by SingleCare

FDA Approves Biktarvy for Use in HIV Regimens

In January 2018, the Federal Drug Administration (FDA) approved the use of Biktarvy for the treatment of HIV infections in adults. Biktarvy (or any other current HIV medicine) cannot cure an HIV infection, nor prevent HIV from developing into AIDS. However, an HIV regimen (a combination of HIV medicines) can help HIV-infected people live longer, and reduce the possibility of ... Continue Reading

FDA Approves Symdeko for Treatment of Cystic Fibrosis

March 26, 2018 by SingleCare

FDA Approves Symdeko for Treatment of Cystic Fibrosis

Symdeko was approved by the FDA in February 2018, for the treatment of certain types of cystic fibrosis, in patients aged 12 years or older. According to Vertex Pharmaceuticals, cystic fibrosis is estimated to affect 75,000 people across North America, Europe, and Australia. Jeffrey Leiden, M.D., Ph.D., president of Vertex (the company behind the drug), says Symdeko’s ... Continue Reading

Next Page »

Never miss out on health news that could impact you and how we can help you save on healthcare.

Recent Posts

  • Protected: About Penguin Pay
  • Report Shows Many Are Prescribed Ineffective Treatment for Lower Back Pain
  • Your Zip Code Could Be An Indicator of Your Health
  • Who’s The Most Likely to Be Uninsured?
  • Penguin Pay Breakthrough! Loans for Prescription Drugs
Wal-Mart.com USA, LLC

Categories

  • Company News
  • Dental
  • Drug News
  • Exercise
  • Family
  • Fitness
  • Health Tips
  • Healthcare
  • Mental Health
  • Research
  • Uncategorized
  • Weekly News Round-up
  • Wellness

Contact Us

  • Monday - Friday
    9am-9pm EST
  • Support (844) 234-3057 Support
  • Provider support 800-960-6918 Provider support
  • 71 Broadway, #255
    New York, NY 10006

SingleCare

  • About Us
  • Mobile Apps
  • Blog
  • Press
  • Member Agreement
  • Privacy Policy

Service areas

  • Prescriptions
  • Dental
  • Vision
  • Video doctor visits

For employers

  • SingleCare for business

For providers

  • Provider information

Support

  • Contact us
  • FAQ
  • Glossary

Social

  • Facebook
  • Twitter
  • LinkedIn

© 2018 SingleCare Administrators. All Rights Reserved.